We determine: 1) whether the addition of asymmetric dimethylarginine (ADMA) reduces nitric oxide (NO)-related metabolites in primary airway epithelial cells under IL-13/ IFNγ stimulation, 2) supplementation of L-arginine/L-citrulline to cultures with high ADMA/iNOS expression is able to redirect iNOS towards NOx production.\ud \ud L-arginine and L-citrulline supplementation are able to increase the formation of NOx (nitrates + nitrates) in human airway epithelial cells, despite treatment with endogenous iNOS inhibitor ADMA. L-arginine and L-citrulline may have a therapeutic potential in diseases in which there is a defective production of NO
Nitric oxide synthase (NOS) converts L-arginine into nitric oxide (NO) and L-Citrulline. In NO-produ...
Nitric oxide synthase (NOS) converts L-arginine into nitric oxide (NO) and L-Citrulline. In NO-produ...
Impaired microcirculation during endotoxemia correlates with a disturbed arginine-nitric oxide (NO) ...
We determine: 1) whether the addition of asymmetric dimethylarginine (ADMA) reduces nitric oxide (NO...
This study was aimed to examine the effect of L-arginine (ARG) exposure on the disposition of asymme...
l-Arginine metabolism including the nitric oxide (NO) synthase and arginase pathways is important in...
l-Arginine metabolism including the nitric oxide (NO) synthase and arginase pathways is important in...
Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), causes u...
The arginine metabolite asymmetric dimethylarginine (ADMA) is a competitive inhibitor and uncoupler ...
Asymmetric dimethylarginine (ADMA) competitively inhibits nitric oxide synthase (NOS). Its levels in...
There is growing evidence that increased levels of the endogenous NO synthase inhibitor asymmetric d...
Background: Disturbance in the delicate balance between L-arginine-metabolizing enzymes such as nitr...
AbstractL-Arginine, the substrate of nitric oxide (NO) synthases (NOSs), is found in the mammalian o...
AbstractOBJECTIVESWe sought to determine whether asymmetric dimethylarginine (ADMA) inhibits nitric ...
Asymmetric dimethylarginine (ADMA, NG, NG-dimethyl-L-arginine) is endogenously produced by asymmetri...
Nitric oxide synthase (NOS) converts L-arginine into nitric oxide (NO) and L-Citrulline. In NO-produ...
Nitric oxide synthase (NOS) converts L-arginine into nitric oxide (NO) and L-Citrulline. In NO-produ...
Impaired microcirculation during endotoxemia correlates with a disturbed arginine-nitric oxide (NO) ...
We determine: 1) whether the addition of asymmetric dimethylarginine (ADMA) reduces nitric oxide (NO...
This study was aimed to examine the effect of L-arginine (ARG) exposure on the disposition of asymme...
l-Arginine metabolism including the nitric oxide (NO) synthase and arginase pathways is important in...
l-Arginine metabolism including the nitric oxide (NO) synthase and arginase pathways is important in...
Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), causes u...
The arginine metabolite asymmetric dimethylarginine (ADMA) is a competitive inhibitor and uncoupler ...
Asymmetric dimethylarginine (ADMA) competitively inhibits nitric oxide synthase (NOS). Its levels in...
There is growing evidence that increased levels of the endogenous NO synthase inhibitor asymmetric d...
Background: Disturbance in the delicate balance between L-arginine-metabolizing enzymes such as nitr...
AbstractL-Arginine, the substrate of nitric oxide (NO) synthases (NOSs), is found in the mammalian o...
AbstractOBJECTIVESWe sought to determine whether asymmetric dimethylarginine (ADMA) inhibits nitric ...
Asymmetric dimethylarginine (ADMA, NG, NG-dimethyl-L-arginine) is endogenously produced by asymmetri...
Nitric oxide synthase (NOS) converts L-arginine into nitric oxide (NO) and L-Citrulline. In NO-produ...
Nitric oxide synthase (NOS) converts L-arginine into nitric oxide (NO) and L-Citrulline. In NO-produ...
Impaired microcirculation during endotoxemia correlates with a disturbed arginine-nitric oxide (NO) ...